pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-539 |
Genomic Coordinates | chr14: 101047321 - 101047398 |
Synonyms | MIRN539, hsa-mir-539, MIR539 |
Description | Homo sapiens miR-539 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-539-3p | ||||||||||||||||||||||||||||
Sequence | 49| AUCAUACAAGGACAAUUUCUUU |70 | ||||||||||||||||||||||||||||
Evidence | Not_experimental | ||||||||||||||||||||||||||||
Experiments | |||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | WDR17 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | WD repeat domain 17 | ||||||||||||||||||||
Transcript | NM_170710 | ||||||||||||||||||||
Other Transcripts | NM_181265 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on WDR17 | |||||||||||||||||||||
3'UTR of WDR17 (miRNA target sites are highlighted) |
>WDR17|NM_170710|3'UTR 1 TAGAAGATTTTTGTCCATGCTTGATTTTTTTTTTTAAAGAAAAACTTTCATGGGTTAGCATTACCTTAATCTTTGTTGCT 81 CAAGTGCCAGAGGTTGGGAGAAGGATTGCAGGTTGGGAGAGGTGGGAAATAGCAGTGAATTTTAGTCATTAACTTCAAAA 161 TATATATATATATATAATTTAAAGGAAAAATAGGTGCCTCCTTTATAAACAGTAATAGCTACGTTTGGGAAGGAGGAAAC 241 ATTTAAATTATAAAGGACTGAATAATCTAAAAAGCATATAAAAGTTTCACACAGCATAAAAGATACCAAAATATCATATG 321 GTTGAAATATTGAAACATATTAAATTGTGCAACACCTAGAATAGTGCTAGACATACAGTAAGTACTTAATGGATATTTGA 401 ATGATTGAATATCTTGAAATGTTGAAATGTAAGGTGTGCACAGTGATCTTCAACTTAACAAACACTTACGTTCTCCTTTA 481 TAAAATGCATAGTAAACCACTAACGTTAGCTGTTTTAATAAAAGTTTTCAGTTATAAGTTTAGTAAATATTAATAAATGG 561 ATACACATTCAAAATACTTTTAAAAAAAAGAAAATGTTACCAGTTTTTTTATCTGAAGTTTAACTGTCCCATTGTAAAGG 641 TGTAAGTTATATAGGCTTGAAAAAAATTGGCGGGTAAAAATCACAAAATGCAGTCGAATATATATATGAAAACTTGCATT 721 AGGTGATAAAGTGACTATTTTAAGAGATTCAGCATGCATGGATATTAGTTTTGATTAATGTGTACAATAATTTACACAGT 801 ATACTCTAGTCAATTTATGTTAACTTTATTTAAAACACAATTTATTTGGCCGGGCACGGTGGCTCACACCTGTAATCTCA 881 GCACTTTGGCAGGCCAAGGCAGGTGGATCACCTGAGGTCAGGAGTTCATGACCAGCCTGGCCAGCATGGTAAAACCCTGT 961 CTCCACTAAAAATACAAAAATTAGCCAGGCATGGTGGCGGGCACCTGTAATCCCAGTTACTTGGGAAGCTGAGGCAGGAG 1041 AATCCCTTGAACCTGGGAGGCAGAGGTTCCAGTGAGCCAAGATCGCACCACTGCACTCCAGCCTGGGCAACAAAGAGCGA 1121 AACTCTGTCTCAAAAAACAAACCAACAAAAACCACAATTGATTTGATGAAAATTAGTTTTAAGTAAATGTTTGTAAATAG 1201 ATATTGGTTGAATTTTTGGATATATTATGTTGATTTAACTTTTAAAATGTTGTTTAAAAGTGTGAAGCTATGAAAAGCCT 1281 GATAATGTGACTACAGATATTTCAGTTGGACTAGAATTCTGACTTTGAAACTTATTAAATTAATGCATACTGGAAGTACT 1361 TTGATACTCAAGTTGTTTCACAAGATTTATAATATAGATGGTTTTGTTTGACTAAAGAATAATCTCATATAACTAGAATA 1441 CTTGTGGCTTTTATTATCTTTAAACTTGTTGCATTTAAAATATTTTTAAAACCTTCTTAACAAAACTTCTTAAAACTGGA 1521 AAAAATATATATTATGTATCTATGTATCATATTTATCACATGACCACTTTTGATTCCTTAAAAAGACATTACAGGCTTAA 1601 ATTCCATTTTATTAAAAAAAAAAAATTGCCTGTAATCCCAGCACTTCAGGAGGCCGAGATGGGCAGATCTTGAGGTCGGT 1681 AGATGGAGACCATCCTGGCCAACATGGTGAAACCCTGTCTCTACTAAAAATACAAAAATTAGCTGGGTGTGGTGGTGTGT 1761 ACCTGTAGTCCCAGCTACCCAGGAAGCTAAGGCAGGAGAATCGCTTGAATCCAGGAGGCGGAGGTTGCAGTGAGCTGAGA 1841 TCGCACTACTGCACTCCAGCCTGGGCGACAGAGCAAGACCACCATCTCCAAAAATTATATATATAAAAATAATTAATATT 1921 ATAGAAGAGAATATACACAACTCAGAGATGCAATGGATAATATAAAAAGAGTACCTGAGATGTATTTTTTTAAACTCTTA 2001 GAGATATCTGTAACTCAAATTTTTCTTAGGTGAGGAGGATTATTAACTGGCACATATGTACTAAAAACCCCTCACTTAAA 2081 AATGGCAGTCTCAATCCTACTGTCATTCTTTTTATTTTAAAATAAATAAATAAGCCTATCTTTTTGTGCTTACATACTTA 2161 AAAGGATATCATTAAGTATATAAACAATCATTACTTCTGTATTTTTAATGAATGCAGGAAAATAATATTTTTATGTATAA 2241 AAGATGAAGAAAAAATTTTGCAAGTCTTTAAGCACATAAATACAACAGAATAGCCACCCAATTTCTGTCTGAAATCTAAA 2321 TTGGATGGATTTGACCATCATTCTATTATCTTTGATTTCTACAATGTCTATATCTTATTACCTATAACTATTAATTTTTC 2401 ATAGAATTATAAATGTCATTTGACTATGTCAATCTGTATATATTGTACCTTAATATGAAAAACAAATTTTTTAATTCATA 2481 AAAGTATTTTTATTAGATTTCATATGCATGAAACCCAAGCAAATTATATGAATTTATTTTACTATTTGAAAATGTTCATA 2561 TTACCAATAATGTGGACAAATTACTTTGCAGGTTTAAATATGCCTCTGTAAAGGAAGAGTCTCATTAGACAATGATTTTT 2641 AAAGCATTGGAAAAATATTTTGCCTGTAAAAGTTAGTAACTAGGTGGTTCACAAAATTACAACATCAAAATAGTTACATC 2721 TTGTGAAAATATATGATTTTTATGTCAATCAAGACAAATGAAATATATATGTATGTGTATATATATACATGTATGTATGA 2801 AATATATATATGTGCGTGTGTGTGTGTATATATATATATATATATATATATTTCTATGAAATTGTCCAGATGTGTTCAGG 2881 AACATGATTGCATTAGAGCAATGACTGTATTTTGTTGTCCTTATAACATTTATATTATTTCAGTTTTAAGTCAAAAGGTA 2961 TTCTGAATATAATAAAAGCCTCACAAATTATTTGTAAAATTTAGTAGTTCATATTTAGTATATCAGTAATATAGAAGACA 3041 TCTTTATAGTCAACTCTTAATTAATGCTTATTGTACCAAATCTTTGAGATATTTGTACATAAATGAAATATGTACTTTCA 3121 TGCTAAAATTATATATCATGACTGTGCTATAATTTGGCATGTCATTATCTAGATTTATATGTATGTACGTATTTCAGGTC 3201 CTTGAAATTTTAATAAATATTACAGTTAAATCCTGATATGACATAGTTAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 116966.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM714642. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM714642 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000393643.2 | 3UTR | AUAUAUGUAUGUGUAUAUAUAUACAUGUAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
65 hsa-miR-539-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT102192 | NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | 2 | 4 | ||||||||
MIRT147308 | KPNA2 | karyopherin subunit alpha 2 | 2 | 8 | ||||||||
MIRT255970 | WDR17 | WD repeat domain 17 | 2 | 2 | ||||||||
MIRT318225 | RREB1 | ras responsive element binding protein 1 | 2 | 4 | ||||||||
MIRT339123 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT341161 | HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 2 | 2 | ||||||||
MIRT439452 | TMED10 | transmembrane p24 trafficking protein 10 | 1 | 1 | ||||||||
MIRT439861 | PTPRS | protein tyrosine phosphatase, receptor type S | 1 | 1 | ||||||||
MIRT440178 | MTRNR2L8 | MT-RNR2-like 8 | 1 | 1 | ||||||||
MIRT440188 | MTRNR2L2 | MT-RNR2-like 2 | 1 | 1 | ||||||||
MIRT440445 | INTS3 | integrator complex subunit 3 | 1 | 1 | ||||||||
MIRT440771 | DST | dystonin | 1 | 1 | ||||||||
MIRT440838 | DDX17 | DEAD-box helicase 17 | 1 | 1 | ||||||||
MIRT440928 | CLTC | clathrin heavy chain | 1 | 1 | ||||||||
MIRT441017 | CANX | calnexin | 1 | 1 | ||||||||
MIRT441020 | CAND1 | cullin associated and neddylation dissociated 1 | 1 | 1 | ||||||||
MIRT441272 | ACTR3C | ARP3 actin related protein 3 homolog C | 1 | 1 | ||||||||
MIRT441275 | ACTR3B | ARP3 actin related protein 3 homolog B | 1 | 1 | ||||||||
MIRT446564 | IDS | iduronate 2-sulfatase | 2 | 2 | ||||||||
MIRT458674 | MRI1 | methylthioribose-1-phosphate isomerase 1 | 2 | 2 | ||||||||
MIRT467486 | SMIM13 | small integral membrane protein 13 | 2 | 2 | ||||||||
MIRT471515 | PCGF3 | polycomb group ring finger 3 | 2 | 6 | ||||||||
MIRT488211 | TESK2 | testis-specific kinase 2 | 2 | 6 | ||||||||
MIRT505413 | TCF7L2 | transcription factor 7 like 2 | 2 | 4 | ||||||||
MIRT506405 | NRF1 | nuclear respiratory factor 1 | 2 | 4 | ||||||||
MIRT508095 | ANKRD33B | ankyrin repeat domain 33B | 2 | 4 | ||||||||
MIRT511883 | GAS1 | growth arrest specific 1 | 2 | 6 | ||||||||
MIRT513413 | RTP4 | receptor transporter protein 4 | 2 | 2 | ||||||||
MIRT515814 | FOCAD | focadhesin | 2 | 2 | ||||||||
MIRT522747 | LNPEP | leucyl and cystinyl aminopeptidase | 2 | 2 | ||||||||
MIRT526664 | IL5RA | interleukin 5 receptor subunit alpha | 2 | 6 | ||||||||
MIRT532113 | G6PC | glucose-6-phosphatase catalytic subunit | 2 | 2 | ||||||||
MIRT547536 | MAML3 | mastermind like transcriptional coactivator 3 | 2 | 2 | ||||||||
MIRT554605 | RPS6KA5 | ribosomal protein S6 kinase A5 | 2 | 2 | ||||||||
MIRT554884 | RCAN2 | regulator of calcineurin 2 | 2 | 2 | ||||||||
MIRT555859 | PANK3 | pantothenate kinase 3 | 2 | 2 | ||||||||
MIRT556601 | LDOC1L | retrotransposon Gag like 6 | 2 | 4 | ||||||||
MIRT565169 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT567099 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | 2 | 2 | ||||||||
MIRT575032 | Fasl | Fas ligand (TNF superfamily, member 6) | 1 | 1 | ||||||||
MIRT609327 | TAS2R30 | taste 2 receptor member 30 | 2 | 4 | ||||||||
MIRT609394 | C11orf74 | chromosome 11 open reading frame 74 | 2 | 2 | ||||||||
MIRT613120 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT614273 | WSCD2 | WSC domain containing 2 | 2 | 2 | ||||||||
MIRT614988 | GID4 | GID complex subunit 4 homolog | 2 | 4 | ||||||||
MIRT619483 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 2 | ||||||||
MIRT622061 | SS18 | SS18, nBAF chromatin remodeling complex subunit | 2 | 2 | ||||||||
MIRT627045 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT657273 | HS3ST3B1 | heparan sulfate-glucosamine 3-sulfotransferase 3B1 | 2 | 2 | ||||||||
MIRT658285 | FASLG | Fas ligand | 2 | 3 | ||||||||
MIRT660838 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT665552 | UCHL5 | ubiquitin C-terminal hydrolase L5 | 2 | 2 | ||||||||
MIRT687560 | MGAT5 | mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase | 2 | 2 | ||||||||
MIRT698864 | SRSF2 | serine and arginine rich splicing factor 2 | 2 | 2 | ||||||||
MIRT699509 | SKIL | SKI like proto-oncogene | 2 | 2 | ||||||||
MIRT706255 | MKLN1 | muskelin 1 | 2 | 2 | ||||||||
MIRT711973 | HOMER2 | homer scaffolding protein 2 | 2 | 2 | ||||||||
MIRT718038 | NIPAL2 | NIPA like domain containing 2 | 2 | 2 | ||||||||
MIRT718766 | ABHD15 | abhydrolase domain containing 15 | 2 | 2 | ||||||||
MIRT721319 | GRHL1 | grainyhead like transcription factor 1 | 2 | 2 | ||||||||
MIRT721439 | NGDN | neuroguidin | 2 | 2 | ||||||||
MIRT721977 | RAD50 | RAD50 double strand break repair protein | 2 | 2 | ||||||||
MIRT725374 | MTF2 | metal response element binding transcription factor 2 | 2 | 2 | ||||||||
MIRT737461 | CTBP1 | C-terminal binding protein 1 | 4 | 0 | ||||||||
MIRT755390 | Sox9 | SRY-box 9 | 4 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|